• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epidemiology of invasive pulmonary aspergillosis in patients with liver failure: Clinical presentation, risk factors, and outcomes.肝衰竭患者侵袭性肺曲霉病的流行病学:临床表现、危险因素及转归
J Int Med Res. 2018 Feb;46(2):819-827. doi: 10.1177/0300060517729907. Epub 2017 Sep 18.
2
Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure.慢性肝衰竭急性发作患者的侵袭性肺曲霉病
J Int Med Res. 2012;40(5):1958-65. doi: 10.1177/030006051204000537.
3
Invasive pulmonary aspergillosis in patients with HBV-related liver failure.HBV 相关肝衰竭患者的侵袭性肺曲霉病。
Eur J Clin Microbiol Infect Dis. 2011 May;30(5):661-7. doi: 10.1007/s10096-010-1137-2. Epub 2011 Jan 4.
4
Hospital-acquired invasive pulmonary aspergillosis in patients with hepatic failure.肝功能衰竭患者医院获得性侵袭性肺曲霉病
BMC Gastroenterol. 2008 Jul 31;8:32. doi: 10.1186/1471-230X-8-32.
5
Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.慢性加急性肝衰竭患者侵袭性肺曲霉病和住院死亡率的危险因素:一项回顾性队列研究。
Int J Med Sci. 2013 Sep 18;10(12):1625-31. doi: 10.7150/ijms.6824. eCollection 2013.
6
Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies.危重病患者合并血液病时的侵袭性肺曲霉病。
Intensive Care Med. 2019 Dec;45(12):1732-1741. doi: 10.1007/s00134-019-05789-6. Epub 2019 Oct 10.
7
[Diagnosis and treatment of invasive pulmonary aspergillosis in 21 children with non-hematologic diseases].[21例非血液系统疾病儿童侵袭性肺曲霉病的诊断与治疗]
Zhonghua Er Ke Za Zhi. 2009 Oct;47(10):730-4.
8
Invasive Pulmonary Aspergillosis in Nonimmunocompromised Hosts.非免疫功能低下宿主的侵袭性肺曲霉病。
Semin Respir Crit Care Med. 2019 Aug;40(4):540-547. doi: 10.1055/s-0039-1696968. Epub 2019 Oct 4.
9
Invasive pulmonary aspergillosis in heart transplant recipients: two radiologic patterns with a different prognosis.心脏移植受者的侵袭性肺曲霉病:两种具有不同预后的影像学表现。
J Heart Lung Transplant. 2014 Oct;33(10):1034-40. doi: 10.1016/j.healun.2014.05.003. Epub 2014 Jun 2.
10
[Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者的侵袭性肺曲霉病]
Rev Iberoam Micol. 2014 Oct-Dec;31(4):237-41. doi: 10.1016/j.riam.2014.07.004. Epub 2014 Sep 30.

引用本文的文献

1
Epidemiology and Inpatient Outcomes of Invasive Aspergillosis in Patients with Liver Failure and Cirrhosis.肝功能衰竭和肝硬化患者侵袭性曲霉病的流行病学及住院结局
J Fungi (Basel). 2025 Apr 23;11(5):334. doi: 10.3390/jof11050334.
2
Predictors for Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: A Retrospective Study.慢性肝衰竭急性发作患者侵袭性肺曲霉病的预测因素:一项回顾性研究
Infect Drug Resist. 2025 Feb 17;18:909-918. doi: 10.2147/IDR.S497840. eCollection 2025.
3
Identifying Gaps in the International Consensus Case Definitions for Invasive Aspergillosis: A Review of Clinical Cases Not Meeting These Definitions.识别侵袭性曲霉病国际共识病例定义中的差距:对不符合这些定义的临床病例的回顾
Open Forum Infect Dis. 2024 Oct 9;11(11):ofae594. doi: 10.1093/ofid/ofae594. eCollection 2024 Nov.
4
Invasive Pulmonary Aspergillosis in Patients with HBV-Related Acute on Chronic Liver Failure.乙型肝炎病毒相关慢加急性肝衰竭患者的侵袭性肺曲霉病
J Fungi (Basel). 2024 Aug 14;10(8):571. doi: 10.3390/jof10080571.
5
Distribution of species and risk factors for aspergillosis in mainland China: a systematic review.中国大陆曲霉病的物种分布及危险因素:一项系统综述
Ther Adv Infect Dis. 2024 Jun 4;11:20499361241252537. doi: 10.1177/20499361241252537. eCollection 2024 Jan-Dec.
6
Prognostic factors and outcomes of invasive pulmonary aspergillosis, a retrospective hospital-based study.侵袭性肺曲霉病的预后因素及结局:一项基于医院的回顾性研究
PeerJ. 2024 Feb 28;12:e17066. doi: 10.7717/peerj.17066. eCollection 2024.
7
Age difference of patients with and without invasive aspergillosis: a systematic review and meta-analysis.比较侵袭性曲霉菌病患者与非侵袭性曲霉菌病患者年龄差异的系统评价和荟萃分析。
BMC Infect Dis. 2024 Feb 19;24(1):220. doi: 10.1186/s12879-024-09109-2.
8
Case Report and Clinical Reasoning: Fulminant Liver Failure and Invasive Aspergillosis Following Ocrelizumab Treatment in a 21 Year-Old Woman.病例报告与临床推理:一名21岁女性接受奥瑞珠单抗治疗后发生暴发性肝衰竭和侵袭性曲霉病
Neurohospitalist. 2023 Jan;13(1):96-102. doi: 10.1177/19418744221130385. Epub 2022 Oct 10.
9
Clinical Risk Score for Invasive Pulmonary Aspergillosis in Patients With Liver Failure: A Retrospective Study in Zhejiang.肝功能衰竭患者侵袭性肺曲霉病的临床风险评分:浙江的一项回顾性研究
Front Med (Lausanne). 2021 Nov 22;8:762504. doi: 10.3389/fmed.2021.762504. eCollection 2021.
10
Patient Characteristics and Risk Factors in Invasive Mold Infections: Comparison from a Systematic Review and Database Analysis.侵袭性霉菌感染的患者特征与风险因素:来自系统评价和数据库分析的比较
Clinicoecon Outcomes Res. 2021 Jun 25;13:593-602. doi: 10.2147/CEOR.S308744. eCollection 2021.

本文引用的文献

1
Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes.重症患者侵袭性曲霉病的流行病学:临床表现、基础疾病及预后
Crit Care. 2015 Jan 12;19(1):7. doi: 10.1186/s13054-014-0722-7.
2
Invasive pulmonary aspergillosis due to Aspergillus lentulus: Successful treatment of a liver transplant patient.由土曲霉引起的侵袭性肺曲霉病:肝移植患者的成功治疗
J Infect Chemother. 2015 Jun;21(6):479-81. doi: 10.1016/j.jiac.2015.02.010. Epub 2015 Mar 6.
3
Invasive aspergillosis in liver transplant recipients: epidemiology, clinical characteristics, treatment, and outcomes in 116 cases.肝移植受者侵袭性曲霉病:116例患者的流行病学、临床特征、治疗及转归
Liver Transpl. 2015 Feb;21(2):204-12. doi: 10.1002/lt.24032.
4
Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis.血清降钙素原和C反应蛋白水平作为肝硬化患者细菌感染标志物的系统评价和Meta分析
Diagn Microbiol Infect Dis. 2014 Sep;80(1):72-8. doi: 10.1016/j.diagmicrobio.2014.03.029. Epub 2014 May 21.
5
Fungal infection in patients with end-stage liver disease: low frequency or low index of suspicion.终末期肝病患者的真菌感染:低频率或低怀疑指数。
Int J Infect Dis. 2014 Jun;23:69-74. doi: 10.1016/j.ijid.2013.12.014. Epub 2014 Apr 12.
6
What's new in invasive pulmonary aspergillosis in the critically ill.危重症患者侵袭性肺曲霉病有哪些新进展。
Intensive Care Med. 2014 May;40(5):723-6. doi: 10.1007/s00134-014-3254-3. Epub 2014 Mar 20.
7
Invasive aspergillosis in patients with cirrhosis, a case report and review of the last 10 years.肝硬化患者侵袭性曲霉病:一例报告及过去十年回顾
Acta Clin Belg. 2013 Sep-Oct;68(5):368-75. doi: 10.2143/ACB.3408.
8
Approach to invasive pulmonary aspergillosis in critically ill patients.危重症患者侵袭性肺曲霉病的处理方法。
Curr Opin Infect Dis. 2014 Apr;27(2):174-83. doi: 10.1097/QCO.0000000000000043.
9
Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.慢性加急性肝衰竭患者侵袭性肺曲霉病和住院死亡率的危险因素:一项回顾性队列研究。
Int J Med Sci. 2013 Sep 18;10(12):1625-31. doi: 10.7150/ijms.6824. eCollection 2013.
10
13th Asia-Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure.第13届亚太临床微生物学与感染大会:肝衰竭诊断与治疗共识指南
Hepatobiliary Pancreat Dis Int. 2013 Aug;12(4):346-54. doi: 10.1016/s1499-3872(13)60055-7.

肝衰竭患者侵袭性肺曲霉病的流行病学:临床表现、危险因素及转归

Epidemiology of invasive pulmonary aspergillosis in patients with liver failure: Clinical presentation, risk factors, and outcomes.

作者信息

Zhang Xuan, Yang Meifang, Hu Jianhua, Zhao Hong, Li Lanjuan

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

出版信息

J Int Med Res. 2018 Feb;46(2):819-827. doi: 10.1177/0300060517729907. Epub 2017 Sep 18.

DOI:10.1177/0300060517729907
PMID:29239266
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5971516/
Abstract

Objective Invasive pulmonary aspergillosis (IPA) is a severe and often lethal infection. The possible risk factors, clinical presentation, and treatment of patients with simultaneous liver failure and IPA have received little attention in previous studies. The aim of this study was to investigate the epidemiology of IPA in patients with liver failure in an effort to reduce patient mortality. Methods The patients with liver failure (including acute liver failure , sub-acute liver failure , acute-on-chronic liver failure and chronic liver failure) were recruited from 2011 to 2016. The clinical data of these patients were retrieved for the study. Results In total, 1077 patients with liver failure were included in this study. Of the 1077 patients, 53 (4.9%) had IPA. Forty-four (83%) patients with IPA died. Independent risk factors for IPA were male sex (hazard ratio [HR] = 2.542), hepatorenal syndrome (HR = 2.463), antibiotic use (HR = 4.631), and steroid exposure (HR = 18.615). Conclusions IPA is a fatal complication in patients with liver failure. Male sex, hepatorenal syndrome, antibiotic use, and steroid exposure were independent risk factors for IPA. When patients with liver failure have these risk factors and symptoms of pneumonia such as cough or hemoptysis, clinicians should be cautious about the possibility of IPA.

摘要

目的 侵袭性肺曲霉病(IPA)是一种严重且常致命的感染。既往研究很少关注同时合并肝衰竭和IPA患者的可能危险因素、临床表现及治疗。本研究旨在调查肝衰竭患者中IPA的流行病学情况,以降低患者死亡率。方法 选取2011年至2016年的肝衰竭患者(包括急性肝衰竭、亚急性肝衰竭、慢加急性肝衰竭和慢性肝衰竭)。检索这些患者的临床资料进行研究。结果 本研究共纳入1077例肝衰竭患者。其中,53例(4.9%)患有IPA。44例(83%)IPA患者死亡。IPA的独立危险因素为男性(风险比[HR]=2.542)、肝肾综合征(HR=2.463)、使用抗生素(HR=4.631)和使用类固醇(HR=18.615)。结论 IPA是肝衰竭患者的致命并发症。男性、肝肾综合征、使用抗生素和使用类固醇是IPA的独立危险因素。当肝衰竭患者存在这些危险因素且有咳嗽或咯血等肺炎症状时,临床医生应警惕IPA的可能性。